Neuroimaging – Multimedia
Poster
MODEL-AD: The Disease Modeling Project
A summary of the Disease Modeling Project for the MODEL-AD consortium.
Listicle
Biggest News Stories of 2017
We have seen some amazing scientific breakthroughs in 2017.
This list highlights some of our favourites.
This list highlights some of our favourites.
Listicle
6 Analytical Advances in 2017
This list highlights six of the most exciting analytical advances from 2017.
Listicle
Top 10 Neuroscience News Stories of 2017
2017 has been an incredible year for neuroscience discoveries and breakthroughs. This list details the top 10 most-read stories of the year.
Poster
Preclinical drug screening in new generation Alzheimer’s disease mouse models: The MODEL-AD Consortium Strategy
A brief overview of the Preclinical Testing Core of the MODEL-AD consortium.
Poster
MEG Resting State Functional Connectivity and Network Topology in Dyslexia Related Genotype
Studying resting state neuro-functional interactions and their network distribution may tell us more about differences in typical and a typical brain development.
Listicle
Beautiful Brain Images
Depicting some of the most beautiful images of the brain: from Santiago Ramón y Cajal’s detailed drawings; to see-through brains with CLARITY; to looking inside the human head with MRI.
Poster
The Impact of MRI on Genitourinary and Gastrointestinal Toxicity after Radiation Therapy
MRI has several advantages relative to other imaging modalities in evaluating, diagnosing, and planning treatment for prostate cancer. However, it is rarely ordered for localized disease. While the diagnostic abilities have been studied, little has been done to associate clinical outcomes with prostate cancer patients who received MRI.
Video
Deciphering the Molecular Pathology of Alzheimer’s Disease
In this webinar the speaker will discuss the use of Alzheimer’s disease transgenic mouse models to evaluate pathological features by both traditional immunohistochemistry and new tissue processing methods that enable whole- brain imaging.
Video
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer
Despite extensive research effort there are no accepted clinical biomarkers that predict for response to systemic combination chemotherapy in advanced CRC.
Advertisement